John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cboe Global Markets
CBOE
$31.4B
| $31.5M | 0.1% |
278,497
+121,442
| +77% | +$13.6M |
|
227
Toronto Dominion Bank
TD
$194B
| $31.2M | 0.1% |
476,312
+127,000
| +36% | +$9.22M |
|
228
Synaptics
SYNA
$3.82B
| $31.1M | 0.1% |
263,131
+250,691
| +2,015% | +$36.7M |
|
229
Tandem Diabetes Care
TNDM
$1.55B
| $31M | 0.1% |
524,249
+485,667
| +1,259% | +$39.9M |
|
|
GRMN
230
Garmin
GRMN
$56.9B
| $31M | 0.1% |
315,293
-134,953
| -30% | -$14.2M |
|
231
SiriusXM
SIRI
$9.67B
| $30.9M | 0.1% |
504,104
-550,873
| -52% | -$34.2M |
|
232
PUT
Scorpio Tankers
STNG
$3.93B
| $30.8M | 0.1% |
+893,900
| New | +$25.8M |
|
233
Intuit
INTU
$100B
| $30.7M | 0.1% |
79,631
-37,297
| -32% | -$15.4M |
|
234
Okta
OKTA
$23.5B
| $30.6M | 0.1% |
338,534
+43,881
| +15% | +$4.74M |
|
235
BP
BP
$115B
| $30.3M | 0.1% |
1,068,967
-1,008,894
| -49% | -$30.9M |
|
236
Carnival Corporation Ltd
CCL
$35.2B
| $30.2M | 0.1% |
3,491,790
-3,660,541
| -51% | -$53.7M |
|
237
QuantumScape Corp
QS
$3.68B
| $30M | 0.1% |
+3,492,443
| New | +$46.6M |
|
238
T. Rowe Price
TROW
$23.8B
| $29.8M | 0.1% |
262,720
+240,986
| +1,109% | +$30.6M |
|
239
Otis Worldwide
OTIS
$27.2B
| $29.4M | 0.1% |
415,556
-467,459
| -53% | -$34.4M |
|
240
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $29.3M | 0.1% |
+504,500
| New | +$31.5M |
|
241
HubSpot
HUBS
$12B
| $29.1M | 0.1% |
96,696
+22,934
| +31% | +$8.38M |
|
242
Incyte
INCY
$25.9B
| $28.9M | 0.1% |
380,099
-178,186
| -32% | -$13.5M |
|
243
VeriSign
VRSN
$25.5B
| $28.7M | 0.09% |
171,727
+115,687
| +206% | +$21.2M |
|
244
Ferrari
RACE
$76.7B
| $28.7M | 0.09% |
156,409
-55,607
| -26% | -$11.1M |
|
245
Schwab US Dividend Equity ETF
SCHD
$111B
| $28.3M | 0.09% |
+1,186,800
| New | +$30.2M |
|
246
3M
MMM
$92.3B
| $28.1M | 0.09% |
+259,571
| New | +$31.4M |
|
247
Teleflex
TFX
$5.88B
| $28M | 0.09% |
113,958
+98,690
| +646% | +$28.8M |
|
248
Texas Instruments
TXN
$241B
| $27.9M | 0.09% |
+181,470
| New | +$30.5M |
|
249
Delek US
DK
$4.38B
| $27.7M | 0.09% |
1,073,096
+518,503
| +93% | +$14M |
|
250
Align Technology
ALGN
$11.5B
| $27.6M | 0.09% |
+116,617
| New | +$35.8M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.